By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Innocoll, Inc. 

42662 Kitchen Prim Court

Ashburn  Virginia  20148  U.S.A.
Phone: 610-459-4278 Fax: 610-459-2893


SEARCH JOBS


Industry
Pharmaceutical






Company News
Innocoll AG Appoints Jose Carmona As Chief Financial Officer 7/1/2015 7:05:54 AM
Innocoll, Inc. (INNL) Announces Qualified Infectious Disease Product (QIDP) Designation For Cogenzia For The Adjunctive Treatment Of Moderate And Severe Diabetic Foot Infection 6/30/2015 7:19:10 AM
Innocoll, Inc. (INNL) To Present At JMP Securities Healthcare Conference 6/18/2015 7:57:07 AM
Innocoll, Inc. (INNL) Announces First Patient Dosed In The Cogenzia COACT-2 Phase III Study For The Treatment Of Diabetic Foot Infection 6/15/2015 8:53:11 AM
Innocoll, Inc. (INNL) Announces First Patient Dosed In The Cogenzia COACT-1 Phase III Study For The Treatment Of Diabetic Foot Infection 5/15/2015 7:08:55 AM
Innocoll, Inc. (INNL) Announces First Quarter Financial And Operating Results 5/14/2015 1:26:49 PM
Innocoll, Inc. (INNL) To Report First Quarter 2015 Financial Results And Host Webcast And Conference Call On May 14, 2015 5/8/2015 7:57:48 AM
Innocoll, Inc. (INNL) Announces Pricing Of Follow-On Offering 4/24/2015 7:34:44 AM
Pivotal Pharmacokinetic Study Of Innocoll, Inc. (INNL)'s Xaracoll(R) Supports Use Of 300 Mg Dose For Phase 3 Clinical Studies In Post-Operative Pain 4/1/2015 6:35:19 AM
Innocoll, Inc. (INNL) Announces Fourth Quarter and Full Year 2014 Financial And Operating Results 3/19/2015 7:58:51 AM
12345678
//-->